来自鲁比亚属的细胞毒和抗瘤剂
Geng Xu1, Meiyu Liu2, Zuobin Wang1,2,3
1School of Life Sciences, Changchun University of Science and Technology, Changchun, 130022, China.
Chemistry & biodiversity
|August 25, 2024
概括
本综述探讨了Rubia物种的抗癌潜力,突出了具有细胞毒性和抗瘤作用的71种化学化合物. 这些发现支持在传统医学中使用鲁比亚来治疗癌症.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 在瘤学瘤学.
背景情况:
- 包括Rubia cordifolia在内的Rubia属在中国传统医学中使用的历史悠久.
- 最近的研究表明,Rubia提取物具有细胞毒性和抗瘤性质.
- 在Rubia物种中识别特定的抗瘤剂是一个活跃的研究领域.
研究的目的:
- 审查来自Rubia属的化学成分的细胞毒性和抗瘤作用.
- 整合有关这些化合物的结构,标和作用机制的信息.
主要方法:
- 关于Rubia物种及其化学成分的研究文献综述.
- 根据其生物活性对已识别的化学物质进行分类.
- 对表现出细胞毒性和抗瘤作用的化合物的结构和机制数据的分析.
主要成果:
- 鉴定和总结了71种具有细胞毒性和抗瘤活性的鲁比亚属的化学物质.
- 将这些化合物分为5个主要类别.
- 详细介绍了它们的结构,生物目标和作用机制.
结论:
- 卢比亚属的化学成分显示出显著的细胞毒性和抗瘤潜力.
- 本综述提供了这些化合物的全面概述,支持进一步研究Rubia衍生的抗癌剂.
- 这些发现证实了Rubia物种用于治疗疾病,特别是癌症的传统药用.
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


